BlackRock Inc. purchased a new position in Avantor, Inc. (NYSE:AVTR - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 70,281,231 shares of the company's stock, valued at approximately $695,784,000. BlackRock Inc. owned about 10.39% of Avantor as of its most recent SEC filing.
Several other large investors have also bought and sold shares of AVTR. Private Management Group Inc. lifted its holdings in shares of Avantor by 50.4% during the fourth quarter. Private Management Group Inc. now owns 2,456,859 shares of the company's stock valued at $28,156,000 after purchasing an additional 823,572 shares in the last quarter. GSA Capital Partners LLP purchased a new position in shares of Avantor in the second quarter worth approximately $800,000. Oppenheimer Asset Management Inc. purchased a new position in shares of Avantor during the 2nd quarter worth $805,000. Assenagon Asset Management S.A. lifted its position in Avantor by 425.0% during the second quarter. Assenagon Asset Management S.A. now owns 556,871 shares of the company's stock valued at $5,513,000 after purchasing an additional 450,801 shares in the last quarter. Finally, Brickwood Asset Management LLP grew its stake in shares of Avantor by 6,891.9% during the 4th quarter. Brickwood Asset Management LLP now owns 3,184,043 shares of the company's stock valued at $36,489,000 after acquiring an additional 3,138,504 shares during the period. 95.08% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several research analysts recently weighed in on the stock. Wells Fargo & Company upped their target price on shares of Avantor from $14.00 to $16.00 and gave the stock an "overweight" rating in a report on Thursday, July 30th. Evercore set a $10.50 price target on shares of Avantor in a research report on Monday, July 6th. Jefferies Financial Group raised Avantor from an "underperform" rating to a "hold" rating and set a $13.00 price objective on the stock in a research note on Wednesday, July 29th. UBS Group set a $8.00 target price on shares of Avantor in a research note on Wednesday, June 24th. Finally, Barclays increased their price target on Avantor from $7.00 to $8.00 and gave the stock an "underweight" rating in a report on Wednesday, June 24th. Two equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Avantor has a consensus rating of "Hold" and a consensus target price of $12.00.
View Our Latest Stock Analysis on AVTR
Avantor Price Performance
Shares of AVTR opened at $14.45 on Monday. The company has a 50 day moving average price of $11.63 and a 200-day moving average price of $9.64. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.18 and a current ratio of 1.78. The stock has a market capitalization of $9.77 billion, a PE ratio of -17.20, a PEG ratio of 10.91 and a beta of 0.89. Avantor, Inc. has a fifty-two week low of $7.26 and a fifty-two week high of $15.93.
Avantor (NYSE:AVTR - Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The company reported $0.21 EPS for the quarter, topping the consensus estimate of $0.19 by $0.02. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.The firm had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.61 billion. During the same period in the previous year, the company posted $0.24 EPS. The business's revenue for the quarter was up .5% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Equities analysts predict that Avantor, Inc. will post 0.81 earnings per share for the current fiscal year.
About Avantor
(
Free Report)
Avantor, Inc NYSE: AVTR is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor's offerings are organized across two primary segments.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Avantor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.
While Avantor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.